Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Tara Cowling's publication output changed over time?
ScholarIQpublication output · 2017–2023
Output grew0% over the shown period — from 1 works in 2017 to 1 in 2023.
1
4
2
2
1
20172019202120222023
What are the most-cited papers on Tara Cowling?
ScholarIQmost cited works
The impact of treatment adherence on clinical and economic outcomes in multiple sclerosis: Real world evidence from Alberta, Canada
Brittany Gerber, Tara Cowling, Guanmin Chen, Michael Yeung, Pierre Duquette, Paola Haddad
S2764622253. 201735 Citations
Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in <scp>Alberta, Canada</scp>: A real‐world evidence study
Guanmin Chen, Megan S. Farris, Tara Cowling, Lionel Pinto, Raina M. Rogoza, Erin S. Mackinnon, Salimah Champsi, Todd J. Anderson
Clinical Cardiology. 202132 CitationsOPEN ACCESS
Treatment and Low-Density Lipoprotein Cholesterol Management in Patients Diagnosed With Clinical Atherosclerotic Cardiovascular Disease in Alberta
Guanmin Chen, Megan S. Farris, Tara Cowling, Stephen Colgan, Pin Xiang, L. Pericleous, Raina M. Rogoza, Ming‐Hui Tai, Todd J. Anderson
Canadian Journal of Cardiology. 201930 Citations
Early access for innovative oncology medicines: a different story in each nation
Tara Cowling, Ransi Nayakarathna, Allison Wills, Dipti Tankala, Nancy Paul Roc, Stéphane Barakat
Journal of Medical Economics. 202323 CitationsOPEN ACCESS
Epidemiology, healthcare resource utilization and healthcare costs for spinal muscular atrophy in Alberta, Canada
Guanmin Chen, Behnam Sharif, Brittany Gerber, Megan S. Farris, Tara Cowling, Czerysh Cabalteja, Jennifer W. Wu, Bridget Maturi, Kristoph Klein-Panneton, Jean K. Mah
Journal of Medical Economics. 202121 CitationsOPEN ACCESS
Related on ScholarIQ
Health Economics and Outcomes Research (United Kingdom)
Institution
The impact of treatment adherence on clinical and economic outcomes in multiple sclerosis: Real world evidence from Alberta, Canada
Paper
Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in <scp>Alberta, Canada</scp>: A real‐world evidence study
Paper
Treatment and Low-Density Lipoprotein Cholesterol Management in Patients Diagnosed With Clinical Atherosclerotic Cardiovascular Disease in Alberta
Paper
Early access for innovative oncology medicines: a different story in each nation
Paper
Epidemiology, healthcare resource utilization and healthcare costs for spinal muscular atrophy in Alberta, Canada
Paper